Literature DB >> 33651654

A systematic literature review of herpes zoster incidence worldwide.

Désirée van Oorschot1, Hilde Vroling2, Eveline Bunge2, John Diaz-Decaro3, Desmond Curran1, Barbara Yawn4.   

Abstract

We conducted a systematic review to characterize the incidence rate of herpes zoster (HZ) in the general population, specifically in individuals ≥50 years of age. A total of 69 publications were included in the review. We found a cumulative incidence of HZ ranging from 2.9-19.5 cases per 1,000 population and an incidence rate of HZ ranging from 5.23-10.9 cases per 1,000 person-years. The cumulative incidence (3.22-11.2 versus 2.44-8.0 cases per 1,000 population) and incidence rates (6.05-12.8 versus 4.30-8.5 cases per 1,000 person-years) were higher in females than males. Studies revealed a trend of increasing incidence of HZ with increasing age and over time. Variations in incidence estimates can be attributed to the various study designs, case ascertainments, age distributions of the population and year of the study. HZ is associated with a substantial disease burden and is expected to increase due to population aging.

Entities:  

Keywords:  Incidence; adults; epidemiology; herpes zoster; review; shingles; vaccination

Mesh:

Substances:

Year:  2021        PMID: 33651654      PMCID: PMC8115759          DOI: 10.1080/21645515.2020.1847582

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  80 in total

1.  Epidemiology of Varicella-Zoster Virus in England and Wales.

Authors:  M Brisson; W J Edmunds
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

2.  The burden of Herpes Zoster and its complications in Poland in according to the age.

Authors:  Piotr Albrecht; Marian Patrzałek; Paweł Goryński
Journal:  Przegl Epidemiol       Date:  2015

3.  Do herpes zoster patients receive antivirals? A Dutch National Survey in General Practice.

Authors:  Wim Opstelten; Gerrit A van Essen; Karel G M Moons; Albert J M van Wijck; François G Schellevis; Cornelis J Kalkman; Theo J M Verheij
Journal:  Fam Pract       Date:  2005-07-08       Impact factor: 2.267

4.  Incidence of herpes zoster and its complications in Germany, 2005-2009.

Authors:  Kathrin Hillebrand; Hélène Bricout; Renate Schulze-Rath; Tania Schink; Edeltraut Garbe
Journal:  J Infect       Date:  2014-09-16       Impact factor: 6.072

5.  [Herpes zoster in Germany. A retrospective analyse of SHL data].

Authors:  J Schiffner-Rohe; S Jow; H M Lilie; I Köster; I Schubert
Journal:  MMW Fortschr Med       Date:  2010-01-14

6.  Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.

Authors:  Yung-Hsiu Lin; Li-Min Huang; I-Shou Chang; Fang-Yu Tsai; Chun-Yi Lu; Pei-Lan Shao; Luan-Yin Chang
Journal:  Vaccine       Date:  2009-11-26       Impact factor: 3.641

7.  A population based study of the epidemiology of Herpes Zoster and its complications.

Authors:  Dahlia Weitzman; Oren Shavit; Michal Stein; Raanan Cohen; Gabriel Chodick; Varda Shalev
Journal:  J Infect       Date:  2013-07-16       Impact factor: 6.072

8.  A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

Authors:  Barbara P Yawn; Patricia Saddier; Peter C Wollan; Jennifer L St Sauver; Marge J Kurland; Lina S Sy
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616

9.  Quantifying the incidence and burden of herpes zoster in New Zealand general practice: a retrospective cohort study using a natural language processing software inference algorithm.

Authors:  Nikki M Turner; Jayden MacRae; Mary L Nowlan; Lynn McBain; Maria H Stubbe; Anthony Dowell
Journal:  BMJ Open       Date:  2018-05-31       Impact factor: 2.692

10.  Varicella-zoster virus susceptibility and primary healthcare consultations in Norway.

Authors:  Grazina Rimseliene; Kirsti Vainio; Moustafa Gibory; Beatriz Valcarcel Salamanca; Elmira Flem
Journal:  BMC Infect Dis       Date:  2016-06-07       Impact factor: 3.090

View more
  9 in total

1.  Non-dermatomal cutaneous herpes zoster infection in a solid-organ transplant patient.

Authors:  Bao Vincent K Ho; Sarah Pourakbar; Christopher Tomassian; Anand Rajpara
Journal:  IDCases       Date:  2022-06-20

2.  Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials.

Authors:  Kevin L Winthrop; Peter Nash; Kunihiro Yamaoka; Eduardo Mysler; Nasser Khan; Heidi S Camp; Yanna Song; Jessica L Suboticki; Jeffrey R Curtis
Journal:  Ann Rheum Dis       Date:  2021-10-06       Impact factor: 19.103

3.  Reactivation of herpes zoster after vaccination with an inactivated vaccine: A case report from Nepal.

Authors:  Sangam Shah; Bikash Baral; Rajan Chamlagain; Hritik Murarka; Yagya Raj Adhikari; Basanta Sharma Paudel
Journal:  Clin Case Rep       Date:  2021-12-07

Review 4.  An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.

Authors:  Paola Pirrotta; Fernanda Tavares-Da-Silva; Maribel Co; Nicolas Lecrenier; Caroline Hervé; Jens-Ulrich Stegmann
Journal:  Drug Saf       Date:  2021-10-07       Impact factor: 5.606

Review 5.  Herpes zoster: A Review of Clinical Manifestations and Management.

Authors:  Anant Patil; Mohamad Goldust; Uwe Wollina
Journal:  Viruses       Date:  2022-01-19       Impact factor: 5.048

6.  Development of a Model for Predicting the Effectiveness of Pulsed Radiofrequency on Zoster-Associated Pain.

Authors:  Zhiyou Peng; Jianguo Guo; Yanfeng Zhang; Xuejiao Guo; Wenguang Huang; Yunze Li; Zhe Yan; Nannan Guo; Daqiang Ke; Li Chen; Jinyan Huang; Zhiying Feng
Journal:  Pain Ther       Date:  2022-01-30

Review 7.  Comparing Prodrugs with Acyclovir for Treating Postherpetic Neuralgia among Herpes Zoster Patients: A Systematic Review and Meta-Analysis.

Authors:  Chung-Hsin Yeh; Ko-Shih Chang; Sheng-Shiung Huang; Shiow-Luan Tsay; Jung-Mei Tsai; Ya-Jung Wang
Journal:  Healthcare (Basel)       Date:  2022-06-24

8.  Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis.

Authors:  Yue Xia; Xue Zhang; Liuren Zhang; Chuanxi Fu
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

9.  Knowledge and Attitudes Concerning Herpes Zoster among People with COPD: An Interventional Survey Study.

Authors:  Barbara P Yawn; Debora D Merrill; Sergio Martinez; Elisabeth Callen; Janice Cotton; Dennis Williams; Natalia Y Loskutova
Journal:  Vaccines (Basel)       Date:  2022-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.